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Abstract sds22 is a regulatory polypeptide of protein phosphat- 
ase-1 that is required for the completion of mitosis in both fission 
and budding yeast. We report here the cDNA cloning of a human 
polypeptide that is 46% identical to yeast sds22. The human 
homolog of sds22 consists of 360 residues, has a calculated molec- 
ular mass of 41.6 kDa and shows a tandem array of 11 leucine- 
rich repeat structures of 22 residues. Northern analysis revealed 
a major transcript of 1.39 kb in all 8 investigated human tissues. 
sds22 was detected by western analysis in both the cytoplasm and 
the nucleus of rat liver cells as a polypeptide of 44 kDa. 
Key words: Cell cycle; Dephosphorylation; Mitosis; Protein 
phosphatase 
1. Introduction 
The serine/threonine protein phosphatases of type-1 (PP-1) 
comprise an abundant and widely distributed group of enzymes 
that all consist of an isoform of the same catalytic subunit 
(PP-1 c) and one or more regulatory subunits [1-3]. The noncat- 
alytic subunits of PP-1 not only determine the activity and 
substrate specificity of the holoenzymes, but also target the 
phosphatase to a particular cellular location. The primary 
structure of several mammalian regulatory polypeptides of 
PP-1 is already known; they include cytoplasmic (inhibitor- 
1/DARPP-32, inhibitor-2) and nuclear (NIPP-1) inhibitory pol- 
ypeptides, a glycogen-binding subunit (G-subunit) and two reg- 
ulatory subunits of the myosin-associated phosphatase of 
smooth muscle [1-6]. 
sds22 was originally identified in Schizosaccharomyces 
pombe as a suppressor of defects in mitosis that result from a 
particular mutation in a PP- lc  isoform [7]. A further functional 
analysis revealed that sds22 is essential for chromosome 
dysjunction during the metaphase/anaphase transition, sds22 
does not itself display a protein phosphatase activity, but may 
facilitate PP-1 mediated ephosphorylation by interaction with 
PP-1 c [7,8]. The central part of sds22 consists of 11 leucine-rich 
repeats that are essential for the interaction with PP - lo  while 
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the N-terminal and C-terminal domains of sds22 are important 
for its stability and subcellular localization, respectively. Re- 
cent studies have led to the identification of an sds22 homolog 
in Saccharomyces cerevisiae that also appears to be essential for 
cell division and also forms a complex with PP- lc  [9,10]. A 
protein homologous to sds22 is also encoded by the Caenorhab- 
ditis elegans genome [11]. 
We report here the molecular cloning of a human protein 
that is highly homologous to sds22 from yeast. It is also shown 
that the human sds22 homolog is expressed in a variety of 
tissues and is present in both the cytoplasm and the nucleus. 
2. Experimental 
2.1. Nucleotide sequence and 5'-RACE analysis 
Most of the nucleotide sequence ncoding human brain sds22 was 
obtained by analysis of a cDNA clone that was deposited as an ex- 
pressed sequence tag (see Results and Discussion). The first 47 nucleo- 
tides were obtained by 5'-RACE-PCR analysis using a human brain 
5"-RACE-ready TM cDNA kit from Clontech. A primary PCR reaction 
(35 cycles) was conducted using an anchor-specific primer and an anti- 
sense primer (GATGTTTCTCAGCAGAT) corresponding to nucleo- 
tides 470486 in Fig. 1. In a secondary PCR amplification (35 cycles) 
the anchor-specific primer was used together with a nested antisense 
primer (ACCTCAAATCCTTCAAT) corresponding to nucleotides 
286-302 in Fig. 1. The products of the second PCR amplification were 
subcloned in the pGEMr vector (Promega), following the instructions 
of the manufacturer, and sequenced using T7 and Sp6 as primers. 
Nucleotide sequencing was performed using the dideoxynucleotide 
chain termination method [12] in an A.L.F. sequenator (Pharmacia 
LKB) with the Pharmacia utoread sequencing kit. Both vector-specific 
and cDNA-specific oligonucleotide primers were used. Sequencing was 
performed on both strands. 
2.2. Northern analys& 
A Northern blot with poly(A) ÷ RNA from eight different human 
tissues (2 gg each) was purchased from Clontech. The membranes were 
developed with a probe encompassing ucleotides 48-1299 of the full- 
length sds22 cDNA (Fig. 1) and 32p-labeled to a specific radioactivity 
of 2 x 10 9 cpm/gg by random priming (Gibco BRL). The blots were 
prehybridized (3h) and hybridized (overnight) at 42°C in the presence 
of 35% formamide, 5 × SSPE, 10 × Denhardt's, 2% SDS and 100/lg/ml 
denatured DNA from salmon sperm [13]. During hybridization the 
probe concentration amounted to 1 ng/ml. Subsequently, the mem- 
branes were washed twice for 10 min at room temperature in 2 x SSC 
plus 0.05% SDS, followed by a 40-min wash at 50°C in 0.1 x SSC plus 
0.1% SDS [13]. Filters were autoradiographed by exposure at -80°C 
with intensifying screens for 72 h. 
2.3. Immunological techniques 
A synthetic peptide, with a sequence corresponding to the 14 C-ter- 
minal residues of human sds22 plus an additional N-terminal cyste- 
ine, was coupled to keyhole limpet hemocyanin and to bovine serum 
albumin, using the Pierce immunogen conjugation kit. Rabbit polyclo- 
nal antibodies to the hemocyanin-coupled p ptides were affinity-puri- 
fied on albumin-coupled peptide that was linked to CNBr-activated 
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Sepharose-4B (Pharmacia LKB). The antibodies were eluted with 'Im- 
muno Pure Gentle Ag/Ab Elution Buffer' (Pierce), extensively dialyzed 
against a buffer containing 20 mM Tris-HCl at pH 7.4 and 150 mM 
NaCI, and stored at -20°C. 
Western analysis on cytosolic and nuclear fractions was essentially 
done as in [14], with the affinity-purified antibodies at a final concentra- 
tion of 2 #g/ml. The nucleoplasm and the nuclear 0.3 M NaC1 extract 
were prepared as described in [14]. The nucleoplasm is defined as the 
supernatant that is obtained by centrifugation (5 min at 13,000 x g) 
after dissolution of the nuclear pellet in a hypotonic medium (buffer C 
in [14]). For the preparation of the cytosolic fraction a liver was homog- 
enized in 2 vols. of a buffer containing 15 mM PIPES at pH 7.2, 80 mM 
KC1, 15 mM NaCI, 0.5 mM dithiothreitol, 0.25 M sucrose and a cock- 
tail of protease inhibitors including 0.5 mM phenyl methanesulphonyl 
fluoride (PMSF), 50 ¢tM 1-chloro-3-tosylamido-7-amino-2-heptanone- 
hydrochloride (TLCK), 50/~M L-1,4'-tosylamino-2-phenylethyl-chlo- 
romethyl ketone (TPCK) and 5/IM leupeptin. The cytosolic fraction 
was obtained by succesive centrifugations at 8,000 x g (10 rain) and 
150,000 x g (35 min). 
3. Results and discussion 
3.1. Identification of a human homolog of  sds22 
The 3'-end of a randomly picked human infant brain cDNA 
clone, which was deposited as an expressed sequence tag 
(EMBL/GenBank accession umber T16129), was found to be 
homologous to sds22 from Schizosaccharomyces pombe. Fur- 
ther sequence analysis of this clone, termed IB3548, demon- 
strated that the 1252 bp insert (nucleotides 48-1299 in Fig. 1) 
was homologous with the complete sds22 cDNA sequence from 
fission and budding yeast (see below). However, 5'-RACE- 
PCR analysis, using Y-anchored human brain cDNA as tem- 
plate, showed that clone IB3548 lacked the 5'-end of the coding 
sequence. Indeed, the 5 ' -RACE-PCR cloning strategy ielded 
two cDNA fragments with a sequence identical to the 5'-end 
of clone IB3548 plus an upstream sequence of 47 nucleotides 
1 GAAT T GGCAGC CAACATC~ GGC GGAAC GC GGC GC GGGGCAGCAACAGT C GC AGGAGAT G 
M A A E R G A G Q Q Q S Q E M 15 
61 AT  GGAGGT GACAGGC GGGT C GAGT C T GAAGAAT C C GGC GATGAAGAAGGGAAGAAACAC 
M E V D R R V E S E E S G D E E G K K H 35 
121 AGCAGT GGCAT C GTGGC C GAC C T CAGT GAACAGAGC TGAAGGATGGGGAGGAGC GGGGG 
S S G I V A D L S E Q S L K D G E E R G 55 
181 GAGGAGGAC cAGAAGAAGAACAT GAGC T GC C T GT GGAC AT  GGAAAC CAT CAAC C T GGAC 
E E D P E E E H E L P V D M E T I N L D 75 
241 AGAGAT GCAGAGGAT GT TGAT TT GAAT CAC TAT  C GCATAGGGAAGAT  GAAGGAT T T GAG 
R D A E D V D L N H Y R I G K I E G F E 95 
301 GTAC T GAAGAAAGTGAAGAC T C T C T GC C T C C GC CAAAATT TAAT TAAAT GCAT T GAGAAT 
V L K K V K T L C L R Q N L I K C I E N 115 
361 C T GGAGGAGC TACAGAGTC TT C GAGAGC T GGAT C T TTAC GACAAC CAGATCAAGAAGATT 
L E E L Q S L R E L D L Y D N Q I K K I 135 
421 GAGAAT C T GGAGGC GC TAACAGAGC T GGAGATT C TAGATATT T C T T TTAAT C T GC T GAGA 
E N L E A L T E L E I L D I S F N L L R 155 
481 AACATC GAAGGGGTT GACAAGTT GACAC GAC TGAAAAAAC TC T TC T T GGT CAACAATAAA 
N I E G V D K L T R L K K L F L V N N K 175 
541 AT  CAGTAAAAT TGAGAAC T TAAGCAAC TTACAT CAAC TACAGAT GC TAGAGC T GGGAT C T 
I S K I E N L S N L H Q L Q M L E L G S 195 
601 AAC C GCAT C C GGGCAAT C GAAAATAT C GACAC C T TAAC CAAC C T GGAGAGT T GT T TT T G 
N R I R A I E N I D T L T N L E S L F L 215 
661 GGG~CAA~TTACTAAAC TTCAC4%ACCTGGATGCGC TCACCAAC CTGACAGTC C TC 
G K N K I T K L Q N L D A L T N L T V L 235 
721 AGTATGCAGAGCAACCGGC TGACCAAGATCGAGGGT CT GCAGAACCTGGTGAACCT GC GG 
S M Q S N R L T K I E G L Q N L V N L R 255 
781 GAGC TGTAC CTTAGC CACAATGGCATC GAGGTCATC GAGGGCC TGGAGAACAATAACAAA 
E L Y L S H N G I E V I E G L E N N N K 275 
841 C T C AC GAT GT T GGACAT T GCAT CAAATAGAAT CAAAAAGAT T GAA~TAT C AGC CAT C TA  
L T M L D I A S N R I K K I E N I S H L 295 
901 ACAGAGC T GCAAGAGT C TGGATGAAC GACAAT C T C C T T GAGAGC T GGAGC GAC C T C GAC 
T E L Q E F W M N D N L L E S W S D L D 315 
961 GAGC T GAAGGGAGC AGGAGC C T GGAGACAGT GTAC C T GGAGC GGAAC C C C T T GCAGAAG 
E L K G A R S L E T V Y L E R N P L Q K 335 
1021 GACCCCCAGTACC~GGAAGGTCATGCTCGCCCTCCCCTCCGTGCGGCAGATCGATGCC 
D P Q Y R R K V M L A L P S V R Q I D A 355 
1081 ACGTTCGTCAGGTTCTGAGTCCTTCTTC414CTCCTCATGTGGTCCCTCTCCTCGGAAGAAC 
T F V R F * 360 
1141 TGCC CAGCCACGGGTTTTTAACCCAC TGTT GC TCCTGAGGTCGTCAC TATATCAACAGT 
1201 CACAAACC CAAT GG~TAA~AC T GAC GATAGC T GGCGC GC GC GAC GC CAC ACAC CA 
1261 TTTTCAGATGCCGT TGC~TTAART C T TGCCACAC TGTC 
Fig. 1. cDNA and deduced amino acid sequences of sds22 from human 
brain. The nucleotide sequence ispresented in the 5'-to-Y direction and 
is numbered on the left. The deduced protein sequence (oneqetter-code) 
is given below the nucleotide sequence and is numbered on the right. 
Also indicated are the putative consensus translation initiator codon 
(bold), the stop codon (asterisk) and two putative polyadenylation 
signals (boxed). 
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Fig. 2. Human sds22 contains 11 leucine-rich repeat structures. The 
repeat motifs are boxed. Also indicated is the consensus sequence for 
the repeat structure. 
that extends the open reading flame by 14 amino acids (nucle- 
otides 147  in Fig. 1). The two PCR fragments differed however 
in the identity of nucleotides 4-6, which were either TTG (Fig. 
1) or AGA (not shown). These differences may reflect an allelic 
variation and/or a PCR-amplification error. 
The combined information, obtained by analysis of clone 
IB3548 and of the RACE-PCR products, suggested a complete 
human sds22 cDNA sequence of 1299 nucleotides (Fig. 1). The 
sequence surrounding the first ATG (bp 16-18) fulfills the 
Kozak [15] requirements for initiation of translation in eucar- 
yotes. Using this ATG as start codon the sds22 cDNA sequence 
showed an open reading flame of 1080 nucleotides, encoding 
a polypeptide of 360 residues with a calculated molecular mass 
of 41,563 Da. Although initiation of translation at internal 
ATGs is rare [15], it cannot be excluded that the second (bp 
58 60) and third (bp 61 63) ATG are also used as (alternative) 
initiator codons, since they also reside in a Kozak consensus 
sequence. The Y-end of the human sds22 cDNA sequence con- 
tained two putative polyadenylation signals, but lacked a 
poly(A)+-tail. 
As has previously also been demonstrated for the yeast 
homologs [7-10], a large fraction of human sds22 (residues 
70-311) consists of 11 leucine-rich tandem repeat structures 
(Fig. 2), also known as LRR motifs that may participate in 
protein-protein interactions [7-10,16]. In contrast to yeast 
sds22, however, all repeats in the human polypeptide are ex- 
actly 22 residues long. Analysis of the deduced primary struc- 
ture also revealed that human sds22 is relatively rich in leucine 
(16.1%), glutamic acid (12.8 %) and asparagine (8.3%), but con- 
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tains only 5 proline residues (1.4%). It is an acidic polypeptide 
(pI = 4.7), although the charge is not distributed evenly in the 
three regions that correspond to functional domains in the 
fission yeast homolog (see Introduction). Indeed, while the 
N-terminus (residues 1-69) is acidic (pI = 4.0), the LRR do- 
main (residues 7~311) is somewhat less acidic (pI = 5.1), and 
the C-terrminus (residues 312-360) is very basic (pI = 10.2). It 
is also worth noting that human sds22 contains putative phos- 
phorylation sites for protein kinases A and C, casein kinase-2 
and tyrosine protein kinases (not shown), suggesting that the 
polypeptide, like the fission yeast homolog [8], is a phosphopro- 
tein. 
An alignment of human sds22 with the homologs from 
Schizosaecharomyces pombe, Saceharomyces cerevisiae and 
Caenorhabditis elegans revealed an extensive homology be- 
tween all polypeptides (not shown). Using the 'bestfit' program 
of the GCG software [17], the identity between human sds22 
and the yeast or C. elegans homologs in the overlapping region 
amounted to 46%. The homology extends to the entire polypep- 
tide chain but is particularly strong in the LRR domain. Unique 
for human sds22 is an extension of 32-38 residues at the 
N-terminus, which accounts for the larger mass of this ho- 
molog. 
3.2. Tissue distribution and subcellular localization 
Northern blot analysis howed one major mRNA species of 
1.39 kb in all 8 investigated human tissues (Fig. 3), indicating 
a ubiquitous expression of sds22. At equal mRNA loading, the 
1.39 kb transcript was particularly abundant in skeletal muscle, 
heart and brain. Compared to the size of this major mRNA 
species, the cDNA encoding sds22 was about 0.1 kb smaller 
(Fig. 1), which is likely to be explained by the missing poly(A) +- 
kb  
9 .5  
7 .5  
/ 
4.4  
2 .4  
1.35  -- 
Fig. 3. Northern blot analysis in various human tissues. Each lane 
contained 2/lg poly(A) + RNA isolated from the indicated tissues. The 
blots were hybridized with a probe corresponding to bp 48-1299 of the 
full-length sequence of sds22 shown in Fig. 1. 
kDa 
100.1  
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43 .5  
/ 
28.4  - -  
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Fig. 4. Subcellular localization of sds22. A cytosolic fraction, the nucle- 
oplasm and a nuclear 0.3 M NaC1 extract were prepared from rat liver 
as indicated in section 2. About 15/lg protein of each fraction was 
subjected to 10% Tricine-SDS-PAGE, transferred to a membrane, and 
probed with antibodies against the C-terminus of sds22. 
tail (Fig. 1). In addition to the major 1.39 mRNA transcript, 
two minor transcripts of 2.0 kb and 1.1 kb were observed (Fig. 
3). 
Antibodies raised against a synthetic peptide with a sequence 
encompassing the 14 C-terminal residues of human sds22 were 
used for western blotting of rat liver fractions (Fig. 4). The 
antibodies recognized a polypeptide of 44.4+0.2 kDa 
(mean + S.E.M; n = 4) in the cytosolic fraction, the nucleo- 
plasm and the nuclear salt extract. However, at equal protein 
loading, the signal was much more intense in the nuclear frac- 
tions, indicating that sds22 is enriched in the nucleus, in agree- 
ment with its subcellular distribution in yeast [7,8]. 
3.3. Conclusions 
Given the extensive overall homology (46%) with yeast sds22, 
we propose that the novel sequence reported here represents he 
human homolog of sds22. The high degree of phylogenetic 
conservation suggests that sds22 fulfills an essential role, which 
agrees with its proposed role in mitosis (see section 1). The 
present data constitute the basis for a functional analysis of 
mammalian sds22. It will be of particular interest to see whether 
the human protein, like the yeast homologs, is associated with 
PP-lc. Preliminary evidence indicates that in a hepatic nuclear 
extract nearly all the type-1 catalytic subunit is associated with 
either NIPP- 1 or an unidentified inhibitory polypeptide of 111 
kDa [14]. However, it cannot be excluded that sds22 is only 
associated with a minor fraction of nuclear PP-lc or that the 
association is lost during tissue fractionation. Alternatively, 
sds22 may not be a true regulatory subunit of PP-1 and may 
only be temporarily associated with the catalytic subunit, for 
example at the end of mitosis. Since hepatocytes are nearly all 
in Go phase of the cell cycle, such an association would have 
been missed. 
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